What is the compensation for the newly appointed executives?

For Brian C. Evanko, effective March 31, 2025, his base salary will be $1,100,000, his 2025 Enterprise Incentive Plan (EIP) target is $2,200,000, and his 2026 Long-Term Incentive (LTI) target is $6,700,000. For Ann M. Dennison, effective March 31, 2025, her base salary will be $800,000, her 2025 EIP target is $1,100,000, her 2026 LTI target is $3,500,000, and she will receive a transitional strategic performance share grant valued at $750,000 for the 2025-2027 period.

When will the separation terms for Eric P. Palmer be disclosed?

The filing states that the terms of any separation arrangement between the Company and Mr. Palmer will be reported on a Form 8-K as required. No specific timeline beyond his departure date of April 26, 2025, is provided for this disclosure.

CI 8-K: Leadership Changes & Regulation FD

Q: What are the key leadership changes announced by The Cigna Group?

Effective March 31, 2025, Brian C. Evanko will assume the role of President and Chief Operating Officer, and Ann M. Dennison has been appointed Executive Vice President and Chief Financial Officer. The filing also states that Eric P. Palmer will be leaving the company on April 26, 2025.

Q: Has The Cigna Group updated its financial outlook for 2025?

No, the filing indicates that The Cigna Group is reaffirming its previously issued financial guidance for the full year 2025. This includes consolidated adjusted income from operations of at least $29.50 per share, and pre-tax adjusted income from operations for Evernorth of at least $7.2 billion and for Cigna Healthcare of at least $4.1 billion.

Summary

The Cigna Group's 8-K filing on March 12, 2025, primarily announces significant leadership changes and reaffirms its financial outlook for 2025. Effective March 31, 2025, Brian C. Evanko will step into the role of President and Chief Operating Officer, and Ann M. Dennison has been appointed Executive Vice President and Chief Financial Officer. These appointments are accompanied by updated compensation packages for both executives. The filing also notes the upcoming departure of Eric P. Palmer, Executive Vice President for Enterprise Strategy and President and CEO of Evernorth Health Services, with separation terms to be disclosed later. In addition to the leadership transitions, the company reaffirmed its previously issued 2025 financial guidance. This includes projected consolidated adjusted income from operations of at least $29.50 per share, Evernorth pre-tax adjusted income from operations of at least $7.2 billion, and Cigna Healthcare pre-tax adjusted income from operations of at least $4.1 billion. These reaffirmations provide stakeholders with continued confidence in the company's near-term financial performance expectations, despite the significant organizational adjustments.

Key Highlights

1Brian C. Evanko appointed President and Chief Operating Officer, effective March 31, 2025.
2Ann M. Dennison appointed Executive Vice President, Chief Financial Officer, effective March 31, 2025.
3New compensation arrangements, including base salary, annual incentive targets, and long-term incentive targets, have been approved for Mr. Evanko and Ms. Dennison reflecting their new roles.
4Eric P. Palmer, Executive Vice President for Enterprise Strategy and President and CEO of Evernorth Health Services, will depart the company effective April 26, 2025.
5The Cigna Group is reaffirming its full-year 2025 consolidated adjusted income from operations guidance of at least $29.50 per share.
6The company is also reaffirming its 2025 pre-tax adjusted income from operations outlook for Evernorth ($7.2 billion) and Cigna Healthcare ($4.1 billion).

Cigna Group 8-K Report, Executive Changes (Mar 13, 2025)

Summary

Key Highlights

Frequently Asked Questions